Literature DB >> 26333519

Impact of preoperative asymptomatic renal dysfunction on clinical course after pancreatoduodenectomy.

Minako Nagai1, Masayuki Sho2, Takahiro Akahori1, Toshihiro Tanaka3, Shoichi Kinoshita1, Hideyuki Nishiofuku3, Satoshi Nishiwada1, Chiho Ohbayashi4, Kimihiko Kichikawa3, Yoshiyuki Nakajima1.   

Abstract

BACKGROUND: Although recent large-scale clinical studies have shown that preoperative renal insufficiency is associated with increased risk of postoperative complications after pancreatoduodenectomy (PD), it is unknown whether asymptomatic renal dysfunction has an impact on postoperative course after PD.
METHODS: Two hundred and fifty-four patients who underwent PD between 2007 and 2013 were enrolled. Renal function was evaluated by the preoperative estimated glomerular filtration rate (eGFR). Patients were divided into two groups according to the cutoff value of 55 of eGFR.
RESULTS: Thirty-five patients were classified as the low eGFR group, while 219 were classified as the normal group. There were differences between groups in age, comorbidity and pancreatic texture. The incidence of overall postoperative complication, grade B/C pancreatic fistula and severe complication in the low eGFR group was significantly higher than that in the normal group. Multivariate analysis identified low eGFR as an independent risk factor for severe postoperative complications and grade B/C pancreatic fistula after PD. However, there were no differences in mortality and survival between the low and normal eGFR groups.
CONCLUSIONS: We have demonstrated for the first time that preoperative asymptomatic renal dysfunction may be a significant risk factor for severe morbidity and clinically relevant pancreatic fistula after PD.
© 2015 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Pancreatoduodenectomy; Postoperative complication; Prognosis; Renal dysfunction; Surgery

Mesh:

Year:  2015        PMID: 26333519     DOI: 10.1002/jhbp.286

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  5 in total

1.  Risk factors of clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy: A systematic review and meta-analysis.

Authors:  Biao Zhang; Qihang Yuan; Shuang Li; Zhaohui Xu; Xu Chen; Lunxu Li; Dong Shang
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

2.  Impact of pretreatment asymptomatic renal dysfunction on clinical course after esophagectomy.

Authors:  Yuki Kirihataya; Kohei Wakatsuki; Sohei Matsumoto; Hiroshi Nakade; Tomohiro Kunishige; Shintaro Miyao; Masayuki Sho
Journal:  Surg Today       Date:  2020-08-29       Impact factor: 2.549

3.  High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma.

Authors:  Sven H Loosen; Frank Tacke; Niklas Püthe; Marcel Binneboesel; Georg Wiltberger; Patrick H Alizai; Jakob N Kather; Pia Paffenholz; Thomas Ritz; Alexander Koch; Frank Bergmann; Christian Trautwein; Thomas Longerich; Christoph Roderburg; Ulf P Neumann; Tom Luedde
Journal:  Carcinogenesis       Date:  2019-08-22       Impact factor: 4.944

4.  A simplified scoring system for the prediction of pancreatoduodenectomy's complications: An observational study.

Authors:  Long Chen; Dai-Wen Su; Fan Zhang; Jun-Yi Shen; Yan-Hong Zhang; Yun-Bing Wang
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

5.  Comprehensive Diagnostic Nomogram for Predicting Clinically Relevant Postoperative Pancreatic Fistula After Pancreatoduodenectomy.

Authors:  Bo Li; Ning Pu; Qiangda Chen; Yong Mei; Dansong Wang; Dayong Jin; Wenchuan Wu; Lei Zhang; Wenhui Lou
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.